# Partner Therapeutics Inc - Inspection Records

Source: https://www.globalkeysolutions.net/companies/partner-therapeutics-inc/837081c1-0ffa-4c06-94c1-4ce65e130882

> Inspection records and compliance data for Partner Therapeutics Inc in Lynnwood, Washington. Access full analysis and detailed observations.

---

## Details

- Name: Partner Therapeutics Inc
- FEI Number: 3007934434
- City: Lynnwood
- State: Washington
- Country Name: United States
- Address Line 1: 2625 162nd St Sw
- Zip Code: 98087

## Related Documents

- [483 - Partner Therapeutics Inc - 2026-07-18](https://www.globalkeysolutions.net/records/483/partner-therapeutics-inc/badba9f3-2dea-4b18-bd48-2af1855d8d47) — source: FDA, date: July 18, 2026
- [FDA Inspection 1179013 - Partner Therapeutics Inc - 2022-07-22](https://www.globalkeysolutions.net/records/fda_inspections/partner-therapeutics-inc/de2f9065-438b-4c5b-9d15-6b12cc43f5b4) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 22, 2022
- [FDA Inspection 997959 - Partner Therapeutics Inc - 2016-11-18](https://www.globalkeysolutions.net/records/fda_inspections/partner-therapeutics-inc/739f0e99-9fa1-4111-bc04-15860cd71f8b) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 18, 2016
- [FDA Inspection 995908 - Partner Therapeutics Inc - 2016-08-26](https://www.globalkeysolutions.net/records/fda_inspections/partner-therapeutics-inc/d9e9a4d4-958b-4bf0-92b0-8f58ad991efe) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 26, 2016
- [FDA Inspection 918635 - Partner Therapeutics Inc - 2015-03-18](https://www.globalkeysolutions.net/records/fda_inspections/partner-therapeutics-inc/93968024-70cb-40b5-b352-15726773c4cc) — classification: Official Action Indicated (OAI), source: FDA, date: March 18, 2015
- [FDA Inspection 833429 - Partner Therapeutics Inc - 2013-05-24](https://www.globalkeysolutions.net/records/fda_inspections/partner-therapeutics-inc/ee878481-02dc-4b0f-a130-d001547a054b) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 24, 2013
- [FDA Inspection 627642 - Partner Therapeutics Inc - 2009-10-28](https://www.globalkeysolutions.net/records/fda_inspections/partner-therapeutics-inc/eb7120bf-35d5-4040-9ae3-cb5bdd2509e5) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 28, 2009

## Related Companies

- [PolyPeptide Laboratories, Inc.](https://www.globalkeysolutions.net/companies/polypeptide-laboratories-inc/9d05664c-4a42-45cc-81f6-ef85c356ecc1)
- [Sigma-Aldrich Manufacturing LLC](https://www.globalkeysolutions.net/companies/sigma-aldrich-manufacturing-llc/e6637246-5655-4a30-849d-a25e3a5cd06c)
- [Almac Sciences Limited](https://www.globalkeysolutions.net/companies/almac-sciences-limited/90ccdc83-facd-4798-aef2-460034d63adf)
- [MSD International GmbH](https://www.globalkeysolutions.net/companies/msd-international-gmbh/a9448cbd-d3cc-4427-a1d5-22dc511c3c07)
- [Kyongbo Pharmaceutical Co., Ltd.](https://www.globalkeysolutions.net/companies/kyongbo-pharmaceutical-co-ltd/6b8fd90f-4fa3-4c7b-9ed6-a8a8f4b511da)
- [SAFC, Inc.](https://www.globalkeysolutions.net/companies/safc-inc/8b9b439f-c427-4b43-85d2-81ce982736be)
- [AmbioPharm, Inc](https://www.globalkeysolutions.net/companies/ambiopharm-inc/6a51f093-2f5b-433d-8e97-8e33820a50bf)
- [Jiangsu Jiaerke Pharmaceuticals Group Corp., Ltd.](https://www.globalkeysolutions.net/companies/jiangsu-jiaerke-pharmaceuticals-group-corp-ltd/7ccd91ae-2b6a-43f7-acc5-6c182cec0d11)
- [SCI Pharmtech Inc.](https://www.globalkeysolutions.net/companies/sci-pharmtech-inc/38edf740-19b5-4fbf-bd65-e8cd87a7b1db)
- [Signa S.A. de C.V.](https://www.globalkeysolutions.net/companies/signa-sa-de-cv/378a704e-5acb-49b8-9cd6-32503b29b3fc)

## Related Officers

- [Seneca D. Toms](https://www.globalkeysolutions.net/people/seneca-d-toms/3eda62a2-4c12-438f-805a-5e3efb0f2f94)
- [Consumer Safety Officer (Inspector)](https://www.globalkeysolutions.net/people/christopher-r-czajka/42defbf3-ea06-4090-8d51-7da2b07d9e84)